Lithium succinate

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Lithium succinate
Lithium succinate.png
Systematic (IUPAC) name
lithium butanedioic acid
Clinical data
AHFS/Drugs.com monograph
Legal status
?
Identifiers
ATC code D11AX04
PubChem CID 10197702
ChemSpider 8373202 YesY
Chemical data
Formula C4H5LiO4 
Mol. mass 124.02 g/mol
 YesY (what is this?)  (verify)

Lithium succinate, the lithium salt of succinic acid, is a drug used in the treatment of seborrhoeic dermatitis[1] and proposed for the treatment of anogenital warts.[2]

References[edit]

  1. ^ Leeming JP (1993). "Use of topical lithium succinate in the treatment of seborrhoeic dermatitis". Dermatology (Basel) 187 (2): 149–50. doi:10.1159/000247228. PMID 8358107. 
  2. ^ Ward KA, Armstrong KD, Maw RD, Winther MD, Gilburt SJ, Dinsmore WW (1997). "A pilot study to investigate the treatment of anogenital warts with Topical Lithium Succinate cream (8% lithium succinate, 0.05% zinc sulphate)". International journal of STD & AIDS 8 (8): 515–7. doi:10.1258/0956462971920677. PMID 9259500.